Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Akebia Therapeutics (AKBA) Prepaid Assets (2016 - 2025)

Akebia Therapeutics (AKBA) has disclosed Prepaid Assets for 10 consecutive years, with $3.8 million as the latest value for Q4 2025.

  • Quarterly Prepaid Assets fell 48.49% to $3.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $3.8 million through Dec 2025, down 48.49% year-over-year, with the annual reading at $3.8 million for FY2025, 48.49% down from the prior year.
  • Prepaid Assets for Q4 2025 was $3.8 million at Akebia Therapeutics, down from $5.3 million in the prior quarter.
  • The five-year high for Prepaid Assets was $42.1 million in Q2 2022, with the low at $3.8 million in Q4 2025.
  • Average Prepaid Assets over 5 years is $18.9 million, with a median of $18.9 million recorded in 2024.
  • The sharpest move saw Prepaid Assets skyrocketed 337.11% in 2021, then tumbled 71.82% in 2024.
  • Over 5 years, Prepaid Assets stood at $33.1 million in 2021, then crashed by 47.95% to $17.2 million in 2022, then increased by 17.36% to $20.2 million in 2023, then tumbled by 63.83% to $7.3 million in 2024, then plummeted by 48.49% to $3.8 million in 2025.
  • According to Business Quant data, Prepaid Assets over the past three periods came in at $3.8 million, $5.3 million, and $7.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.